블로그

• 사이버나이프, 전립선암 치료 효과 입증 Oncology에 발표한 ‘국소 전립선암에 대한 로봇 정위체부 방사선 치료 후 10년 결과와 생화학적 및 임상적 결과의 상관관계(Correlations of biochemical and outcomes with 10-year results after robotic stereotactic body radiotherapy for localized prostate cancer blog.naver.com · 2025.11.13
• Cardiovascular, cancer, and infection risks of Janus kinase inhibitors in rheumatoid arthritis ... Abstract Background Evolving evidence suggests that patients undergoing treatment with Janus kinase inhibitors (JAKi) may face an increased risk of cardiovascul blog.naver.com · 2025.06.16
• Impacts of genomic alterations on the efficacy of HER2-targeted antibody–drug conjugates in ... antibody–drug conjugates (ADCs) have revolutionized the treatment landscape of metastatic breast cancer and perfor....... blog.naver.com · 2025.08.04
• RET inhibition overcomes resistance to combined CDK4/6 inhibitor and endocrine therapy in ER+ ... cancer Background: Combined CDK4/6 inhibitor (CDK4/6i) and endocrine therapy significantly improve the outcome of patients with advanced estrogen receptor-positive (ER+) breast cancer. blog.naver.com · 2025.07.10
• The Translational Research Program in Cancer Differences across Populations The Translational Research Program in Cancer Differences across Populations Background: Colorectal cancer (CRC) incidence and mortality vary substantially across populations. blog.naver.com · 2025.07.03
• Hormonal Therapy and Cardiovascular Health: Examining the Risk Among Premenopausal Women ... diagnosed with breast cancer, posing a significant health risk alongside cancer itself.1 Women diagnosed , alcohol, sedentary lifestyle, and diet), a burden of comorbidities, and the cardiovascular effects blog.naver.com · 2025.06.20
• Overall survival after CDK4/6 inhibitor dose reduction in women with metastatic breast cancer Breast cancer is the most common cancer in women, and the first-line treatment for patients with hormone-receptor All women with metastatic breast cancer initiating first-line t....... blog.naver.com · 2025.07.08
• Sensitivity Measures in Studies of Cancer Early Detection Biomarkers Sensitivity Measures in Studies of Cancer Early Detection Biomarkers Background: The sensitivity of a cancer screening biomarker to detect prevalent preclinical cancer drives screening benefit. blog.naver.com · 2025.07.01
• Progression-Free Survival and Overall Survival of CDK 4/6 Inhibitors Plus Endocrine Therapy in ... Progression-Free Survival and Overall Survival of CDK 4/6 Inhibitors Plus Endocrine Therapy in Metastatic Breast Cancer: A Systematic Review and Meta-Analysis Abstract The introduction of CDK4/6 inhibitors blog.naver.com · 2025.07.07
• Temporal trends and disparities by race and ethnicity in treatment of women diagnosed with ... Temporal trends and disparities by race and ethnicity in treatment of women diagnosed with advanced hormone examined disparities in treatment initiation by race and ethnicity. blog.naver.com · 2025.06.30

← 이전 9 페이지 다음 →